BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9554868)

  • 1. 2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).
    Hansen DW; Peterson KB; Trivedi M; Kramer SW; Webber RK; Tjoeng FS; Moore WM; Jerome GM; Kornmeier CM; Manning PT; Connor JR; Misko TP; Currie MG; Pitzele BS
    J Med Chem; 1998 Apr; 41(9):1361-6. PubMed ID: 9554868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase.
    Hagen TJ; Bergmanis AA; Kramer SW; Fok KF; Schmelzer AE; Pitzele BS; Swenton L; Jerome GM; Kornmeier CM; Moore WM; Branson LF; Connor JR; Manning PT; Currie MG; Hallinan EA
    J Med Chem; 1998 Sep; 41(19):3675-83. PubMed ID: 9733492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.
    Webber RK; Metz S; Moore WM; Connor JR; Currie MG; Fok KF; Hagen TJ; Hansen DW; Jerome GM; Manning PT; Pitzele BS; Toth MV; Trivedi M; Zupec ME; Tjoeng FS
    J Med Chem; 1998 Jan; 41(1):96-101. PubMed ID: 9438025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPA250 [3-(2,4-difluorophenyl)-6-[2-[4-(1H-imidazol-1-ylmethyl) phenoxy]ethoxy]-2-phenylpyridine], a novel orally effective inhibitor of the dimerization of inducible nitric-oxide synthase, exhibits an anti-inflammatory effect in animal models of chronic arthritis.
    Ohtsuka M; Konno F; Honda H; Oikawa T; Ishikawa M; Iwase N; Isomae K; Ishii F; Hemmi H; Sato S
    J Pharmacol Exp Ther; 2002 Oct; 303(1):52-7. PubMed ID: 12235232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effect of the oligomeric stilbene alpha-Viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase.
    Chung EY; Kim BH; Lee MK; Yun YP; Lee SH; Min KR; Kim Y
    Planta Med; 2003 Aug; 69(8):710-4. PubMed ID: 14531020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
    Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
    J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of inducible nitric oxide synthesis by the herbal preparation Padma 28 in macrophage cell line.
    Moeslinger T; Friedl R; Volf I; Brunner M; Koller E; Spieckermann PG
    Can J Physiol Pharmacol; 2000 Nov; 78(11):861-6. PubMed ID: 11100933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluations of N-(substituted benzoylamino)-5-carbethoxymethyl-1,2,3,6-tetrahydropyridines as potential antiinflammatory agents.
    Yoon K; Wilson T; Williams S; Redda K
    Drugs Exp Clin Res; 2000; 26(3):73-82. PubMed ID: 10941599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lipopolysaccharide-induced expression of inducible nitric oxide synthase by phenolic (3E)-4-(2-hydroxyphenyl)but-3-en-2-one in RAW 264.7 macrophages.
    Tsao LT; Tsai PS; Lin RH; Huang LJ; Kuo SC; Wang JP
    Biochem Pharmacol; 2005 Aug; 70(4):618-26. PubMed ID: 15998510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2291-4. PubMed ID: 12161118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
    Strub A; Ulrich WR; Hesslinger C; Eltze M; Fuchss T; Strassner J; Strand S; Lehner MD; Boer R
    Mol Pharmacol; 2006 Jan; 69(1):328-37. PubMed ID: 16223957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of N-(substituted benzoylamino)-4-ethyl-1,2,3,6-tetrahydropyridines on nitric oxide generation in stimulated raw 264.7 macrophages.
    Yoon K; Soliman K; Redda K
    Drugs Exp Clin Res; 2002; 28(2-3):83-90. PubMed ID: 12224381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
    Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
    Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
    Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
    J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines.
    Kawanaka Y; Kobayashi K; Kusuda S; Tatsumi T; Murota M; Nishiyama T; Hisaichi K; Fujii A; Hirai K; Nishizaki M; Naka M; Komeno M; Nakai H; Toda M
    Bioorg Med Chem; 2003 Mar; 11(5):689-702. PubMed ID: 12537998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells.
    Bae IK; Min HY; Han AR; Seo EK; Lee SK
    Eur J Pharmacol; 2005 Apr; 513(3):237-42. PubMed ID: 15862806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and activity of 2-imidazol-1-ylpyrimidine derived inducible nitric oxide synthase dimerization inhibitors.
    Davey DD; Adler M; Arnaiz D; Eagen K; Erickson S; Guilford W; Kenrick M; Morrissey MM; Ohlmeyer M; Pan G; Paradkar VM; Parkinson J; Polokoff M; Saionz K; Santos C; Subramanyam B; Vergona R; Wei RG; Whitlow M; Ye B; Zhao ZS; Devlin JJ; Phillips G
    J Med Chem; 2007 Mar; 50(6):1146-57. PubMed ID: 17315988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock.
    Kang JS; Yoon YD; Cho IJ; Han MH; Lee CW; Park SK; Kim HM
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1187-94. PubMed ID: 15537821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
    Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
    Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.